The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
CCL
Vol.
25
No.
6
June 28, 2002
- Iressa Shrinks Some Lung Tumors, Reduces Symptoms In Phase II Trial
- New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds
- Docetaxel As Adjuvant Therapy Shows Benefit Over Standard
- QOL Of Anemic Patients Improved With Darbepoetin
- UC Davis Study Finds Patients Need Practical Information
- Clinical Trials Approved By NCI CTEP During May
TCL
Vol.
28
No.
28
July 12, 2002
- Letter From Congress Prompts NCI To Pull Abortion Fact Sheet From Web
- Dalton To Head Moffitt Cancer Center; HHS Appoints Gerberding CDC Director
- SEC Investigating Bristol-Myers’ Sales Statements
- Surprise Finding On HRT Stops Large Trial, Women Advised To Reconsider Long-Term Use Due to Increased Breast Cancer Risk
- Monroe Wall, Co-Discoverer Of Taxol, Camptothecin, Dead At 85
- Funding Opportunity.
TCL
Vol.
28
No.
29
July 19, 2002
- Preventive Services Task Force Urges Colorectal Cancer Screening for 50 and Up; Advises Against Tamoxifen for Women at Low to Average Breast Cancer Risk
- Okunieff To Lead SWOG Radiation Committee
- More Bad News For Estrogen: Increased Ovarian Cancer Risk
- UC Davis Cancer Center Wins NCI Designation
- H. Lee Moffitt Center Reads The Cancer Letter
- Funding Opportunities.
CCL
Vol.
25
No.
7
July 26, 2002
- New Therapeutic Options Enhance Breast Cancer Treatment: ASCO Reports
- Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia
- Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer
- Study Finds No Link Between Pill And Breast Cancer Risk
- Vasectomy Doesn’t Increase Prostate Cancer Risk
- Drug Slows Tumor Growth In Metastatic Kidney Cancer
- STI-571 Effects Are Lasting Against GI Stromal Tumors
- Monoclonal Antibody Improves AML Response To Therapy
- Protocols Approved During the Month of June 2002
TCL
Vol.
28
No.
31
August 02, 2002
- Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market
- Bush Appoints Niederhuber Chairman of NCAB
- Senate Committee Approves $27 Billion for NIH, $4.6 Billion for NCI
- Senate Report Calls on NCI To Expand Research in Survivorship, CAM, GYN Cancers, And Fund Five Pancreatic SPOREs
- Sharon Murphy To Head New Research Center in San Antonio
- The Cancer Letter Takes Summer Publication Break.
CCL
Vol.
25
No.
8
August 30, 2002
- Better Access Key To Higher Survival For African-Americans With Colon Cancer
- NCI Grant Supports Jefferson Trial To Study Test To Diagnose Colorectal Cancer Spread
- Lung Cancer Survivors Claim Good QOL, Despite Challenges
- “Acceptable” Images Found In Chest Scans Using Half Dose
- More Radiation Increases Prostate Cancer Response
- More Workers Quit Smoking When Health Messages Combined
- Local Labs Not As Accurate As Central Testing For HER2
- FDA Approves Aranesp For Chemo-Induced Anemia
- Clinical Trials Approved By NCI CTEP During July
